Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Michel Khalaf is President & CEO at MetLife. OQRO lists 14 transactions filed with the SEC under this name, the latest on Nov 12, 2026, each linked to the official Form 4.
President & CEO
Disclosures on record
14
Companies involved
1
MetLifeMET
14 disclosures · Dec 2024 – Nov 2026 · 2 sold
Nov 10, 2026Sold~$19.3Mdisclosed Nov 12
DetailsOfficial recordNov 10, 202635Kdisclosed Nov 12
DetailsOfficial recordNov 10, 202691Kdisclosed Nov 12
DetailsOfficial recordNov 10, 202695Kdisclosed Nov 12
DetailsOfficial recordNov 10, 202629Kdisclosed Nov 12
DetailsOfficial recordNov 10, 202635Kdisclosed Nov 12
DetailsOfficial recordNov 10, 202691Kdisclosed Nov 12
DetailsOfficial recordNov 10, 202695Kdisclosed Nov 12
DetailsOfficial recordNov 10, 202629Kdisclosed Nov 12
DetailsOfficial recordMar 2, 202622Kdisclosed Mar 4
DetailsOfficial recordFeb 24, 202669Kdisclosed Feb 26
DetailsOfficial recordFeb 24, 202681Kdisclosed Feb 26
DetailsOfficial recordFeb 24, 202643Kdisclosed Feb 26
DetailsOfficial recordDec 13, 2024Sold~$1.73Mdisclosed Dec 17
DetailsOfficial recordMichel Khalaf has no open-market purchase on record since 2021. Sales in 4 of the 6 years since 2021.
Michel Khalaf reported 0 open-market purchases and 5 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $19.3M1×1 trade |
| 2024 | — | $3.08M2×2 trades |
| 2022 | — | $4.15M1×1 trade |
| 2021 | — | $2.6M1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
As of the latest filing on , Michel Khalaf reported holding 759,013 shares of MetLife (MET), worth about $77.9M at the last close of $103 (Nov 13, 2026). In the last 12 months, Michel Khalaf sold $19.3M in 1 sale.
MetLife's proxy statement reports total compensation of $22.4M for Michel Khalaf for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 29, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| MetLife MET | 759,013 | 759K direct | $103 | $77.9M | Nov 10, 2026 |
Is this Michel Khalaf’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 10, 2026, Michel Khalaf reported holding 759,013 shares of MetLife (MET). At the last close of $103 on Nov 13, 2026, that is about $77.9M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Michel Khalaf reported 1 open-market sale worth $19.3M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
MetLife's proxy statement reports total compensation of $22.4M for Michel Khalaf for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Michel Khalaf has no open-market purchase on record since 2021. Sales in 4 of the 6 years since 2021.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2026.
MetLife (MET), from 2021 to 2026: 0 purchases and 5 sales.
Michel Khalaf reported 0 open-market purchases and 5 sales here, 2021 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.